---
figid: PMC2852629__nihms-191871-f0002
figlink: /pmc/articles/PMC2852629/figure/F2/
number: F2
caption: Ovarian Steroid Hormone Synthesis. In premenopausal women, the ovaries are
  the principal source of E2. The first, rate-limiting step in is the transfer of
  cholesterol from the cytosol to the inner membrane of the mitochondrion with the
  aid of StAR, and the conversion of cholesterol to pregnenolone. After side chain
  cleavage and utilizing the delta-5 or delta-4 pathway, androstenedione is the key
  intermediary. A fraction of androstenedione is directly “aromatized” to E1, which
  is subsequently converted to E2. Alternatively, androstenedione is converted to
  testosterone, which in turn undergoes conversion to E2 by aromatase. In postmenopause,
  the circulating steroids androstenedione, testosterone, and E1 become the major
  precursor substrates of E2 production in peripheral and estrogen target tissues.
pmcid: PMC2852629
papertitle: Estrogenic Compounds, Estrogen Receptors and Vascular Cell Signaling in
  the Aging Blood Vessels.
reftext: Dia A. Smiley, et al. Curr Med Chem. ;16(15):1863-1887.
pmc_ranked_result_index: '45199'
pathway_score: 0.8627471
filename: nihms-191871-f0002.jpg
figtitle: Ovarian Steroid Hormone Synthesis
year: ''
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2852629__nihms-191871-f0002.html
  '@type': Dataset
  description: Ovarian Steroid Hormone Synthesis. In premenopausal women, the ovaries
    are the principal source of E2. The first, rate-limiting step in is the transfer
    of cholesterol from the cytosol to the inner membrane of the mitochondrion with
    the aid of StAR, and the conversion of cholesterol to pregnenolone. After side
    chain cleavage and utilizing the delta-5 or delta-4 pathway, androstenedione is
    the key intermediary. A fraction of androstenedione is directly “aromatized” to
    E1, which is subsequently converted to E2. Alternatively, androstenedione is converted
    to testosterone, which in turn undergoes conversion to E2 by aromatase. In postmenopause,
    the circulating steroids androstenedione, testosterone, and E1 become the major
    precursor substrates of E2 production in peripheral and estrogen target tissues.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP19A1
  - COMT
  - CYP17A1
  - CYP11A1
  - Androstenedione
  - Cholesterol
  - DHEA
  - Dehydroepiandrosterone
  - Estradiol
  - Estriol
  - Estrone
  - 17-Hydroxypregnenolone
  - Pregnenolone
  - Progesterone
  - Dihydrotestosterone
  - Testosterone
  - Androstenediol
  - 17-Hydroxyprogesterone
genes:
- word: aromatase
  symbol: aromatase
  source: hgnc_alias_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: COMT
  symbol: COMT
  source: hgnc_symbol
  hgnc_symbol: COMT
  entrez: '1312'
- word: p450c17
  symbol: P450C17
  source: hgnc_alias_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: p450scc
  symbol: P450SCC
  source: hgnc_alias_symbol
  hgnc_symbol: CYP11A1
  entrez: '1583'
chemicals:
- word: Androstenedione
  source: MESH
  identifier: D000735
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: DHEA
  source: MESH
  identifier: D003687
- word: Dehydroepiandrosterone
  source: MESH
  identifier: D003687
- word: Estradiol
  source: MESH
  identifier: D004958
- word: Estriol
  source: MESH
  identifier: D004964
- word: Estrone
  source: MESH
  identifier: D004970
- word: 17-Hydroxypregnenolone
  source: MESH
  identifier: D006907
- word: Pregnenolone
  source: MESH
  identifier: D011284
- word: Progesterone
  source: MESH
  identifier: D011374
- word: Dihydrotestosterone
  source: MESH
  identifier: D013196
- word: Testosterone
  source: MESH
  identifier: D013739
- word: Androstenediol
  source: MESH
  identifier: D015114
- word: 17-Hydroxyprogesterone
  source: MESH
  identifier: D019326
diseases: []
figid_alias: PMC2852629__F2
redirect_from: /figures/PMC2852629__F2
figtype: Figure
---
